Symptomatic improvement in gastroesophageal reflux disease (GERD) following laparoscopic Roux-en-Y gastric bypass |
| |
Authors: | EE Frezza S Ikramuddin W Gourash T Rakitt A Kingston J Luketich P Schauer |
| |
Institution: | (1) Department of Surgery, Presbyterian University Hospital, University of Pittsburgh, 200 Lothrop Street, Pittsburgh, PA 15213-2582, USA, US |
| |
Abstract: | Background: The purpose of this study was to determine the effect of laparoscopic Roux-en-Y gastric bypass (LRYGBP) on symptomatic
control of gastroesophageal reflux disease (GERD). Methods: Morbidly obese patients (n = 435) who underwent LRYGBP for morbid
obesity were assessed for changes in GERD symptoms, quality of life, and patient satisfaction after surgery. Results: A total
of 238 patients (55%) had evidence of chronic GERD, and 152 patients (64%) voluntarily participated in the study. The mean
body mass index (BMI) was 48 kg/m2. The mean excess weight loss was 68.8% at 12 months. There was a significant decrease in
GERD-related symptoms, including heartburn (from 87% to 22%, p<0.001); water brash (from 18% to 7%, p<0.05); wheezing (from
40% to 5%, p<0.001) laryngitis (from 17% to 7%, p<0.05); and aspiration (from 14% to 2%, p<0.01) following LRYGBP. Postoperatively,
the use of medication decreased significantly both for proton pump inhibitors (from 44% to 9%, p<0.001) and for the H2 blockers
(from 60% to 10%, p<0.01). SF-36 physical function scores and the mental component summary scores improved after the operation
(87 vs 71; p<0.05 and 83 vs 66; p<0.05, respectively). Overall patient satisfaction was 97%. Conclusion: LRYGBP results in
very good control of GERD in morbidly obese patients with follow-up as late as 3 years. Morbidly obese patients who require
surgery for GERD may be better served by LRYGBP than fundoplication because of the additional benefit of significant weight
loss. |
| |
Keywords: | |
本文献已被 PubMed SpringerLink 等数据库收录! |
|